Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXTI research report →
Range $43 – $125
Price Chart
About the company
AXT, Inc. is a company dedicated to the design, development, production, and worldwide distribution of both compound and single-element semiconductor substrates. Leveraging its proprietary vertical gradient freeze technology, the firm manufactures these essential components.
- CEO
- Morris S. Young
- IPO
- 1998
- Employees
- 1,541
- HQ
- Fremont, CA, US
Get TickerSpark's AI analysis on AXTI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $2.29B
- P/E
- 74.38
- Fwd P/E
- 29.58
- PEG
- 0.01
- P/S
- 13.39
- P/B
- 2.43
- EV/EBITDA
- 39.58
- Div Yield
- 0.00%
- Gross Margin
- 44.02%
- Op Margin
- 19.55%
- Net Margin
- 18.53%
- ROE
- 5.40%
- ROIC
- 2.53%
Latest fiscal year · YoY change
- Revenue
- $88.33M-11.1%
- Gross Profit
- $11.24M-52.8%
- Op Income
- $-21,976,000
- Net Income
- $-21,260,000-82.9%
- EPS
- $-0.49-81.5%
- OCF Growth
- -5.5%
- FCF Growth
- -5.0%
- Beta
- 2.01
- RSI (14)
- 35
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
AXT reported a sharp Q3 revenue and profit surge on booming indium phosphide demand, with margins expanding and backlog topping $500 million.· October 29, 2026
- Q3 revenue was $73.4 million, up 54% sequentially and 162% year over year, driven mainly by $54.3 million of indium phosphide sales.
- Non-GAAP gross margin reached 56.1% versus 45.0% in Q2 and 22.4% in Q3 2025; management said it expects margins to keep improving and could begin with a 6% handle in Q4.
- Non-GAAP EPS was $0.41, up from $0.19 in Q2; cash, cash equivalents and investments rose to $825.9 million.
- Backlog exceeded $500 million, and management said demand continues to outstrip supply, with customers on allocation.
- AXT raised Q4 guidance to about $90 million of realizable revenue and non-GAAP EPS of $0.57 to $0.59.
AXT reported third-quarter 2026 revenue of $73.4 million, up 54% from $47.6 million in Q2 2026 and up 162% from $28.0 million in Q3 2025. Non-GAAP gross margin was 56.1% versus 45.0% in Q2 and 22.4% in Q3 2025; GAAP gross margin was 56.0% versus 44.9% and 22.3%, respectively. Non-GAAP EPS was $0.41 versus $0.19 in Q2; GAAP EPS was $0.39 versus $0.17. Cash, cash equivalents and investments increased by $77 million to $825.9 million, and DSO improved to 49 days. For Q4, management said about $90 million of revenue is already realizable across substrates and raw materials, with non-GAAP EPS guided to $0.57 to $0.59 and GAAP EPS to $0.56 to $0.58.
Morris Young said AXT is in a “pivotal” period and described the business as being at an inflection point, driven by exceptionally strong indium phosphide demand for AI data center optical connectivity. He emphasized rapid capacity expansion, new furnace designs that improve productivity, and customer migration to larger-diameter, higher-value substrates. His tone was highly confident and energetic, but he repeatedly stressed execution and said the company is “laser-focused” on scaling to meet demand.
Gary Fischer highlighted the quarter’s operating leverage: non-GAAP operating profit was $29.5 million, and non-GAAP net profit was $26.8 million or $0.41 per diluted share. He noted gross margin gains were driven by higher volume, favorable mix, improved productivity and larger wafer sizes, while raw material costs are rising but are being outweighed by other factors. On the balance sheet, he pointed to cash and investments of $825.9 million, accounts receivable up only $3 million, net inventory up about $7.4 million, and a $43.5 million Lumentum prepayment that sits as a liability until product shipments convert it to revenue.
Analysts pressed management on whether gross margins had peaked, how much further they can rise, and whether Q4/Q27 capacity builds could create indium phosphide overcapacity. Management said margins have not peaked, could start the next quarter with a “6” handle, and are being helped by volume, mix, larger wafers and better furnace productivity. On capacity, management said customers are on allocation, demand is still growing faster than supply, and they are not worried about overcapacity in 2027 or 2028. Asked about the backlog jump, management said the increase to more than $500 million is largely run-rate business rather than mainly long-term supply agreements.
The call showed strong demand momentum, especially for indium phosphide tied to AI data center optical connectivity, with backlog above $500 million and customers asking for more capacity. Management sees continued margin expansion from mix shift, larger substrates and productivity gains, and they believe the move to 4-inch and 6-inch wafers supports both ASPs and long-term growth.
Management acknowledged rising raw material costs and said gross margin improvement may not be linear because the business is changing quickly. There are also execution risks around ramping new capacity, including 6-inch production and facility conversion work, even though demand is currently far ahead of supply. Finally, the company noted that some markets, such as gallium arsenide, may be seasonally down in Q4.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 93.9%
- Shares Outstanding
- 65.72M
- Float Shares
- 61.73M
of shares held by institutions
296 13F filers
Buy/sell ratio 3.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 9.53M | ▲ 4.46M |
| Vanguard Capital Management LLC | 2.77M | ▲ 46.11K |
| State Street Corp | 2.59M | ▲ 1.10M |
| Marex Group Ltd | 2.45M | ▼ 1.11M |
| Vanguard Portfolio Management LLC | 2.36M | ▲ 599.92K |
| Ubs Group AG | 2.13M | ▲ 1.48M |
| Vanguard Group Inc | 2.11M | ▼ 96.32K |
| Geode Capital Management, LLC | 1.80M | ▲ 62.16K |
| Goldman Sachs Group Inc | 1.49M | ▲ 665.74K |
| D. E. Shaw & Co., Inc. | 1.30M | ▼ 950.61K |
| Invesco Ltd. | 1.25M | ▲ 105.78K |
| Price T Rowe Associates Inc | 1.25M | ▼ 72.97K |
Held by 307 ETFs
Biggest fund positions in AXTI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 26 | YOUNG MORRIS S | other | 10,526 |
| Nov 17, 26 | YOUNG MORRIS S | other | 10,526 |
| Oct 27, 26 | YOUNG MORRIS S | other | 23,350 |
| Oct 27, 26 | FISCHER GARY L | other | 8,524 |
| Jun 10, 26 | LEBLANC LEONARD J | sell | 500 |
| Aug 7, 26 | LEBLANC LEONARD J | sell | 2,000 |
| Aug 17, 26 | LEBLANC LEONARD J | sell | 4,000 |
| Jul 16, 26 | Duh Jia-bin | other | 0 |
| Jul 16, 26 | Duh Jia-bin | other | 0 |
| Jun 17, 26 | Liu Tracy | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AXTI coverage
Recent articles, reports, and earnings notes.
No research on AXTI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AXTI report →